Allodynic Therapeutics is a pharmaceutical company that develops low-dose naltrexone-based products. Its proprietary lead therapeutic candidate, Low-Dose Naltrexone and acetaminophen (LDNA) combination targets neuropathic pain, migraine, back pain, and emotional pain.